Journal article

Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions

Zhibin Chen, Danny Liew, Patrick Kwan

Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2014

Grants

Funding Acknowledgements

Z. Chen reports no disclosures. D. Liew has received research grants from the National Health and Medical Research Council of Australia, the Australian Research Council, and the National Heart Foundation of Australia. He/his institution has also received speaker or consultancy fees and/or research grants from Pfizer, AbbVie, Sanofi, AstraZeneca, GlaxoSmithKline, and Amgen. P. Kwan has received research grants from the National Health and Medical Research Council of Australia, the Australian Research Council, the US NIH, Hong Kong Research Grants Council, Innovation and Technology Fund, Health and Health Services Research Fund, and Health and Medical Research Fund. He/his institution also received speaker or consultancy fees and/or research grants from Eisai, GlaxoSmithKline, Johnson & Johnson, Pfizer, and UCB Pharma. Go to Neurology.org for full disclosures.